Hemophilia overview

Revision as of 00:04, 1 September 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Hemophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia overview

CDC on Hemophilia overview

Hemophilia overview in the news

Blogs on Hemophilia overview

Directions to Hospitals Treating Hemophilia

Risk calculators and risk factors for Hemophilia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Hemophilia usually is inherited. "Inherited” means that the disorder is passed from parents to children through genes. People born with hemophilia have little or no clotting factor. Clotting factor is a protein needed for normal blood clotting. There are several types of clotting factors. These proteins work with platelets to help the blood clot. Platelets are small blood cell fragments that form in the bone marrow—a sponge-like tissue in the bones. Platelets play a major role in blood clotting. When blood vessels are injured, clotting factors help platelets stick together to plug cuts and breaks on the vessels and stop bleeding. The two main types of hemophilia are hemophilia A and hemophilia B. If you have hemophilia A, you're missing or have low levels of clotting factor VIII (8). About 8 out of 10 people who have hemophilia have type A. If you have hemophilia B, you're missing or have low levels of clotting factor IX (9). Rarely, hemophilia can be acquired. "Acquired” means you aren't born with the disorder, but you develop it during your lifetime. This can happen if your body forms antibodies (proteins) that attack the clotting factors in your bloodstream. The antibodies can prevent the clotting factors from working.[1]

Historical Perspective

Hemophilia was first described by Dr. John Conrad Otto, a Philadelphia physician in 1803 who wrote an account about "a hemorrhagic disposition existing in certain families." He recognised that the disorder was hereditary and that it affected mostly males and rarely females.

Classification

Hemophilia may be classified into three subtypes based on lack of functional clotting factors:hemophilia A , hemophilia B, Hemophilia C.

Pathophysiology

Development of hemophilia is the result of multiple genetic mutations. The genes involved in the pathogenesis of hemophilia include the F8 gene in hemophilia A and F9 gene in hemophilia B.

Causes

Hemophilia is caused by a mutation in a gene involved in the synthesis of clotting factor proteins.

Differentiating Hemophilia from other diseases

Hemophilia must be differentiated from other diseases that lead to spontaneous bleeding and bleeding following injuries or surgery such as von Willebrand disease, liver failure-early or end staged, thrombocytopenia, vitamin K deficiency, disseminated intravascular coagulation, uremia, congenital afibrinogenemia, factor V deficiency, factor X deficiency as seen in amyloid purpura, glanzmann's thrombasthenia, bernard-soulier syndrome, factor XII deficiency and C1INH deficiency.


References

  1. "NIH Hemophilia Overview".

Template:WH Template:WS